MEDPRIN is short for “Medical Printing”. We specialize in research, development, and manufacturing of high-end medical devices, with a focus on tissue regenerative implantable medical devices.

About MEDPRIN

About MEDPRIN

12 YEARS

We have got 285 patent applications worldwide and 146 patents authorized. Our products have been CE marked and sold to more than 70 countries. Culture featured in “Care, Creativity, Cooperation”.

CARE


Connecting patients and physicians worldwide

CREATIVITY


Exploring new technologies and developing new products

COOPERATION


Win-win collaboration for a brighter future

Corporate Vision

To become one of the global leaders in implantable medical device and to serve patients and physicians worldwide with outstanding products and impressive services.

Global Coverage


Step by step, Medprin gradually expands its coverage across the world, and competes with leading medical device companies.

  • 70 +
    Countries and Regions
  • 200000 +
    Patients

Global Coverage


Step by step, Medprin gradually expands its coverage across the world, and competes with leading medical device companies.

  • 70

    Countries and Regions

  • 200000

    Patients

Medprin has established our own interdisciplinary innovation team covering the whole industrial chain of high performance medical device development. 

Medprin has a market-driven product development strategy and works with KOLs for product development.


Show more

Milestone

To be continued

StypCel,Immiseal,Retissue and more new products

2018

1

ReDura™ - National Patent Excellent Award               

2

Additive manufacturing facilities - National Patent Sliver Award

3

LivPrint™- CE Certificate

2017

1

Member of National Additive Manufacturing Association

2

Certificate of Intellectual Property Management System

2016

1

Top 7th Globally Rank of 3D Bio-Printing Patent Number

2

ReDura™ - Nomination For National Industry Awards Recranio ™ CFDA

3

National Biological 3D Printing and Implantable Medical Device Research Center

2015

1

NeoDura ™ CE

2014

1

ReDura ™ CFDA

2013

1

National Enterprise Postdoctoral Program

2012

1

National High-Tech Enterprise

2011

1

ReDura ™ CE, ISO 13485

2010

1

Over 4,000 square meters GMP facility and animal study facility are established

2008

1

Founded